VCYT

25.4001.44%
RC

Rebecca Chambers

Independent Director

Ms. Rebecca Chambers is Independent Director of Alamar Biosciences, Inc. from January 2026. Ms. Chambers serves as Executive Vice President and Chief Financial Officer at Veracyte, Inc. since July 19, 2021. She was Independent Director at Inari Medical, Inc. since June 21, 2021 until its acquisition by Stryker in February 2025. Ms. Chambers had been Chief Financial Officer of Outset Medical, Inc. since June 2019 until July 16, 2021. Ms. Chambers served at Illumina where she served in a number of roles: as the Vice President, Financial Planning and Analysis from July 2017 to May 2019, as Vice President, Investor Relations and Treasury from April 2015 to June 2017 and as Senior Director of Investor Relations from October 2012 to April 2015. Ms. Chambers served as Head of Investor Relations and Corporate Communications at Myriad Genetics, from January 2011 to October 2012 and Senior Manager of Investor Relations at Life Technologies from May 2009 to December 2010. Ms. Chambers has a decade of healthcare leadership experience. Ms. Chambers has led numerous financial functions as well as served in leadership roles in investor relations for publicly traded companies in the healthcare space. She also previously held positions with Bank of America and Millennium Pharmaceuticals that was acquired by Takeda Pharmaceuticals Co. Ms. Chambers holds a B.S. in Biology from John Carroll University and an M.B.A. from The S.C. Johnson Graduate School of Management, Cornell University.

公司职务